8-K
Current Report
Grace Therapeutics, Inc. Filed Acc 0000950170-22-019002
Executive or director change · Shareholder vote results · Regulation FD disclosure
- Item 5.02 Departure or appointment of directors or officers
- Item 5.07 Submission of matters to a vote of security holders
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading acst-20220928.htm…